Biotech / Neurology Funding

Sector profile · 1 tracked rounds · $9.1 million tracked capital

Capvizr tracks Biotech / Neurology funding activity across newly funded companies, lead investors, hiring signals, and market narratives.

Top company Amyl TherapeuticsLargest round $9 million1 deals

Recent Biotech / Neurology rounds

Amyl Therapeutics · $9.1 million · Series A · September 1, 2026

Market context

Biotech / Neurology deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.

Open Biotech / Neurology in the interactive Capvizr dashboard →

Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime